Journal Name: JAMA Oncology
Journal Type: Q1
ISSN: 23742437, 23742445
Country: United States
Subject Area and Category: Biochemistry, Genetics and Molecular Biology Cancer Research Medicine Oncology
Publisher: American Medical Association
Research Ranking: 7
Publication Type: Journals
H-Index: 193
Coverage: 2015-2025
Editors-in-Chief: Mary L. Disis
Research Impact Score: 61.6
Impact Factor: 22.5
SCIMAGO SJR: 8.377
APC Cost: $5000 USD for manuscripts submitted on or before January 15, 2025, and $6000 USD for manuscripts submitted on or after January 16, 2025
Submission Link: https://jamanetwork.com/journals/jamaoncology
Contact Email: jamaonc@jamanetwork.org
Address: 850 Republican St, Box 358050, Seattle
Overview
JAMA Oncology is a prestigious, peer-reviewed medical journal that publishes high-quality research, clinical studies, and expert commentary focused on oncology. As part of the JAMA Network, it serves as a vital resource for oncologists, researchers, and healthcare professionals dedicated to advancing cancer treatment and improving patient outcomes. With a strong commitment to disseminating cutting-edge scientific knowledge, JAMA Oncology has become a cornerstone in the field of cancer research.
A Brief Introduction to JAMA Oncology
Launched in 2015, JAMA Oncology quickly became a trusted source of clinical and translational research on all aspects of cancer, including prevention, diagnosis, treatment, and management. The journal covers a wide range of cancer-related topics, from molecular and genetic mechanisms to the latest advancements in immunotherapy, chemotherapy, and targeted treatments. It also delves into policy and healthcare systems' impact on cancer care delivery.
JAMA Oncology is renowned for its rigorous editorial standards and impact factor, attracting submissions from leading researchers and institutions worldwide. The journal's aim is to inform oncologists, clinicians, and other healthcare providers about groundbreaking innovations in cancer care, ensuring that new research reaches the right audience.
Types of Content in JAMA Oncology
JAMA Oncology offers a variety of content formats, making it a comprehensive resource for the oncology community. The primary types of content published include:
-
Original Research: This includes high-quality clinical and translational studies, often featuring new cancer therapies, diagnostic tools, and innovative treatment regimens.
-
Reviews and Meta-Analyses: These articles provide a thorough evaluation of existing research, offering insights into cancer trends, treatment effectiveness, and emerging therapies.
-
Clinical Trials: The journal features comprehensive reports on significant clinical trials, providing detailed data on treatment regimens and patient outcomes.
-
Editorials and Commentaries: Written by experts in the field, these articles offer opinions, in-depth analysis, and reflections on current trends, emerging therapies, and healthcare policies affecting cancer care.
-
Case Reports: Real-world examples that highlight unique patient cases or treatment outcomes, often contributing to the understanding of rare cancers or novel approaches to treatment.
Key Areas of Focus
JAMA Oncology focuses on various cancer types and key oncology subfields. Some of the core areas covered include:
-
Cancer Genetics and Genomics: The journal highlights the role of genetic research in understanding the biology of cancer, as well as the development of personalized therapies.
-
Immunotherapy and Targeted Therapies: As cancer treatment continues to evolve, JAMA Oncology frequently explores new immunotherapies, targeted therapies, and their clinical implications.
-
Cancer Prevention and Early Detection: The journal publishes studies on cancer prevention, screening, and diagnostic innovations aimed at improving early detection and survival rates.
-
Health Policy and Cancer Care Delivery: Acknowledging that cancer care extends beyond treatment, JAMA Oncology often discusses healthcare policies, access to care, and strategies to improve healthcare systems globally.
Why JAMA Oncology Matters
JAMA Oncology is crucial in the landscape of cancer research and clinical care for several reasons. Its role in disseminating high-impact, evidence-based research ensures that oncology professionals have access to the latest findings that shape clinical practice. Additionally, it fosters collaboration across different disciplines, encouraging a holistic approach to cancer treatment. The journal’s broad reach and influence make it an essential tool for staying current with the rapidly evolving field of oncology.
For professionals in the oncology community, JAMA Oncology remains a vital source of information, offering insights that not only enhance clinical practice but also contribute to the global effort to combat cancer.
About
JAMA Oncology, a renowned journal published by the American Medical Association (AMA), is one of the leading platforms for cutting-edge research in the field of oncology. This prestigious peer-reviewed medical journal is dedicated to advancing the science of cancer treatment, prevention, and care through high-quality clinical and translational research. JAMA Oncology plays a pivotal role in the oncology community, offering readers an up-to-date understanding of the latest developments in cancer therapy, diagnostics, and the overall management of cancer patients.
What is JAMA Oncology?
JAMA Oncology is part of the JAMA Network, which includes a collection of journals focusing on various medical specialties. Established in 2015, the journal has quickly gained recognition for its rigorous research and its ability to shape cancer care practices worldwide. The journal publishes original research articles, systematic reviews, meta-analyses, and commentary pieces, all aimed at improving the understanding of cancer and enhancing patient outcomes.
Scope of JAMA Oncology
The journal covers a broad spectrum of topics in oncology, including but not limited to:
-
Cancer Epidemiology: Understanding the distribution and determinants of cancer across populations.
-
Cancer Treatment and Therapy: Studies on innovative cancer treatments, including chemotherapy, immunotherapy, targeted therapies, and precision medicine.
-
Cancer Prevention: Research on lifestyle factors, screening methods, and early detection techniques aimed at preventing cancer.
-
Oncology Drug Development: Reviews and findings on the development of novel drugs, biologics, and their clinical applications in treating various types of cancer.
-
Palliative Care: Addressing the needs of cancer patients through end-of-life care and symptom management.
-
Survivorship: Focusing on improving the quality of life for cancer survivors and addressing long-term health issues following cancer treatment.
JAMA Oncology publishes articles that not only impact medical research but also influence clinical practice and healthcare policy, making it a critical resource for oncologists, researchers, healthcare providers, and policy-makers.
Impact of JAMA Oncology in Cancer Research
One of the significant contributions of JAMA Oncology is its role in disseminating groundbreaking clinical trials and data. Its publications have a far-reaching impact on the oncology field, influencing treatment protocols and the standards of care in cancer management. Researchers and oncologists rely on the findings published in JAMA Oncology to make informed decisions about cancer therapies, improving patient outcomes and contributing to the ongoing fight against cancer.
The journal is also instrumental in introducing new perspectives on cancer prevention and early detection. Its comprehensive reviews and studies provide insights into how healthcare systems and individuals can work together to reduce cancer risk and ensure early diagnosis.
Access and Submission Process
JAMA Oncology is accessible to a global audience, offering both print and online access to its content. Researchers and clinicians can subscribe to receive updates or visit the journal's website to explore recent issues and articles.
For researchers wishing to submit their work to JAMA Oncology, the submission process is straightforward. Authors are required to submit their manuscripts through the journal’s online submission system, ensuring that their research undergoes a thorough peer-review process before publication.
Scope
JAMA Oncology, a leading peer-reviewed medical journal, plays a pivotal role in disseminating cutting-edge research in the field of oncology. As an authoritative source, it focuses on clinical and experimental studies, providing oncologists, researchers, and healthcare professionals with the latest insights into cancer treatment, prevention, and diagnostics. Published by the American Medical Association, JAMA Oncology has a broad scope that includes a variety of important topics within the realm of cancer care, addressing both the scientific community and the broader healthcare sector.
1. Clinical Oncology Research
One of the primary focuses of JAMA Oncology is the publication of clinical trials and research studies. These articles contribute significantly to the understanding of new cancer treatments, therapies, and clinical practices. From novel chemotherapy regimens to immunotherapy breakthroughs, JAMA Oncology features research that directly influences patient care and clinical decision-making. The journal covers a wide range of cancers, including but not limited to breast cancer, lung cancer, colorectal cancer, and hematologic malignancies.
2. Cancer Prevention and Screening
Beyond treatment, JAMA Oncology addresses cancer prevention and early detection. Research on screening methodologies, such as mammography, colonoscopy, and genetic testing, plays a crucial role in reducing cancer mortality rates. The journal regularly publishes studies that explore risk factors, preventive measures, and lifestyle interventions that can help in minimizing cancer incidence across various populations. These articles are vital for healthcare providers aiming to implement evidence-based strategies for cancer prevention and early diagnosis.
3. Cancer Genetics and Molecular Biology
Another key area of focus within JAMA Oncology is the exploration of cancer genetics and molecular biology. In recent years, the journal has provided valuable insights into the genetic mutations and molecular pathways that drive cancer progression. These studies are essential in understanding how cancer cells evolve and how treatments can be tailored to target specific genetic alterations. JAMA Oncology also discusses advancements in precision medicine, where targeted therapies based on genetic profiling offer personalized treatment options for patients.
4. Oncological Innovations and Therapies
JAMA Oncology publishes content related to innovative cancer therapies and treatments. From cutting-edge immunotherapies to advancements in chemotherapy and radiation treatment techniques, the journal highlights studies that introduce novel approaches to managing cancer. The exploration of CAR T-cell therapies, checkpoint inhibitors, and other immune-based therapies has transformed cancer treatment, making JAMA Oncology an essential resource for professionals seeking the latest developments in the field.
5. Palliative Care and Survivorship
Cancer care does not end with treatment. The journal also addresses the aspects of palliative care and survivorship, which are vital to improving the quality of life for cancer patients. Topics related to pain management, mental health, and the psychosocial aspects of cancer care are regularly featured. Additionally, JAMA Oncology explores the long-term effects of cancer treatment and how survivors can be supported in managing their health post-treatment.
6. Health Policy and Disparities in Cancer Care
The journal is also committed to addressing the broader societal issues related to cancer, including health policy, healthcare disparities, and access to care. Articles examining the economic burden of cancer treatment, access to cancer care for underserved populations, and policies influencing cancer research and patient outcomes are critical components of JAMA Oncology. These studies aim to inform public health policies and improve cancer care on a global scale.